Bernstein analysts has recently figured selling animal health is "a real possibility" for Bayer and suggested management to consider it for pharma's sake.
As activist investor William Ackman, a thorn in Zoetis' side for two years, reported that he'd sold off his stake, the animal health giant reported Q4 numbers showing a shaped-up bottom line—the very thing Ackman been pushing for.
After two years of implementing an across-the-board efficiency plan, fine-tuning its product portfolio and getting manufacturing up to speed on Apoquel, animal health giant Zoetis is seeing the fruits of its labors.
Last year, the Centers for Disease Control and Prevention released a report from a survey of more than 10,000 veterinarians revealing that the profession takes a major toll on mental health. Now animal health giant Zoetis is stepping forward to offer support to working veterinarians.
Wireless sensors that clip to cows’ ears are helping farmers monitor activity levels and feeding patterns of the animals, and by extension improving the monitoring for early signs of disease. Now, several companies are angling to grab a piece of this growing market.
